• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17290 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     NIHR Health Technology Assessment programme Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: evolving portrait of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) in Québec, an evaluation in the real-world context of care, 2013 to 2018]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: RebinynTM (nonacog beta pegol) – coagulation factor IX (recombinant), notice of inclusion on the Liste des produits du système du sang du Québec]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: recommendations concerning the information required to monitor nusinersen use in real-world settings]
2020     NIHR Health Technology Assessment programme Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation
2020     Swiss Federal Office of Public Health (FOPH) Glinides and glitazones in the treatment of type 2 diabetes
2020     Norwegian Institute of Public Health (NIPH) [Hyperbaric oxygen therapy for radiation-induced cystitis]
2020     Health Technology Wales (HTW) Single-operator per-oral cholangioscopy for the management of hepatobiliary-pancreatic disorders
2020     Health Technology Wales (HTW) Virtual reality therapy for the management of procedure-related pain
2020     Health Technology Wales (HTW) Remote monitoring of blood glucose in women with gestational diabetes
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Chloroquine et Hydroxychloroquine dans le traitement de la COVID-19
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19 : Complément d’informations du 22 Mai 2020
2020     Andalusian Health Technology Assessment Area (AETSA) Cognitive training effectiveness for mild to moderate dementia patients. A systematic review
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) DISINFECTION CHAMBERS/TUNNELS IN THE CONTEXT OF COVID-19 PANDEMIC
2020     Andalusian Health Technology Assessment Area (AETSA) Genetic risk prediction test for cardiovascular disease
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2020     Andalusian Health Technology Assessment Area (AETSA) Efficacy, effectivity and safety of physical therapies for neuromuscular diseases: systematic review
2020     Andalusian Health Technology Assessment Area (AETSA) Effectiveness and safety of MAGnetic Expansion Control (MAGEC) growing rods. Evidence Update.
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Treatment of benign thyroid by thermal laser or radiofrequency ablation]
2020     NIHR Health Technology Assessment programme Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review
2020     NIHR Health Technology Assessment programme Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review
2020     NIHR Health Technology Assessment programme Occupational advice to help people return to work following lower limb arthroplasty: the OPAL intervention mapping study
2020     NIHR Health Services and Delivery Research programme Medication management in older people: the MEMORABLE realist synthesis
2020     NIHR Health Technology Assessment programme Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients who require modification of the usual ordinary diet due to mucositis]
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients with moderate-severe malnutrition undergoing active treatment]
2020     Norwegian Institute of Public Health (NIPH) Abdominal aorta aneurysm (AAA) screening of men aged 65
2020     Health Technology Wales (HTW) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of the SARS-COV-2 virus in people with suspected COVID-19
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: continuous glucose monitoring system (Dexcom G6, Dexcom)]
2020     NIHR Health Technology Assessment programme Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020     Swiss Federal Office of Public Health (FOPH) [Dual antiplatelet therapy following percutaneous coronary intervention]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use of immunoglobulins in hematology]
2020     NIHR Health Technology Assessment programme Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use of immunoglobulins in clinical immunology]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: use of sedation and general anesthesia in pediatric dental care]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the therapeutic value of hyperbaric oxygen (HBO) on children with cerebral palsy]
2020     Austrian Institute for Health Technology Assessment (AIHTA) Genetic testing in the context of familial hypercholesterolaemia management. Organisational and ethical implications (part 1), and economic aspects (part 2)
2020     Austrian Institute for Health Technology Assessment (AIHTA) [Lung cancer screening in risk groups]
2020     NIHR Health Services and Delivery Research programme Access to primary and community health-care services for people 16 years and over with intellectual disabilities: a mapping and targeted systematic review
2020     Basque Office for Health Technology Assessment (OSTEBA) [Efficacy and safety of mechanical thrombectomy in the treatment of patients with ischaemic stroke beyond 6 hours after onset or with an unknown time of onset]
2020     Ontario Health Proton beam therapy for cancer
2020     Austrian Institute for Health Technology Assessment (AIHTA) Lung cancer screening in risk groups: a review-update of the economic evidence (Part II)
2020     Basque Office for Health Technology Assessment (OSTEBA) [Neonatal hearing screening programmes: A systematic review of economic evaluation studies and descriptive analysis of Spanish regional programmes]
2020     Ontario Health Transcatheter aortic valve implantation in patients with severe aortic valve stenosis and low surgical risk
2020     Ontario Health Automated CT perfusion imaging to aid in the selection of patients with acute ischemic stroke for mechanical thrombectomy
2020     Ontario Health Home narrowband ultraviolet B phototherapy for photoresponsive skin conditions
2020     Ontario Health Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: The Argus II retinal implant]
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: approach to managing access to cancer care: a review of the literature and practices]
2019     NIHR Health Technology Assessment programme Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     NIHR Health Technology Assessment programme Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]leukemia]
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia]
2019     NIHR Horizon Scanning Centre (NIHR HSC) An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019     Norwegian Institute of Public Health (NIPH) Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: breast tomosynthesis and breast cancer screening]
2019     NIHR Health Technology Assessment programme Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Stereotactic neurosurgery frameless. The iSYS1® Robotic device]
2019     Norwegian Institute of Public Health (NIPH) Disease modifying treatments for relapsing remitting multiple sclerosis. A health economic evaluation
2019     Norwegian Institute of Public Health (NIPH) Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2019     Andalusian Health Technology Assessment Area (AETSA) PET usefulness in non-oncological indications
2019     Norwegian Institute of Public Health (NIPH) Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019     Andalusian Health Technology Assessment Area (AETSA) Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019     Norwegian Institute of Public Health (NIPH) Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
2019     Norwegian Institute of Public Health (NIPH) Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk – Part 2. Health economic evaluation
2019     Norwegian Institute of Public Health (NIPH) Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke
2019     Norwegian Institute of Public Health (NIPH) Hyperbaric oxygen therapy for osteonecrosis
2019     NIHR Public Health Research (PHR) programme Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence
2019     Adelaide Health Technology Assessment (AHTA) Alpha Thalassaemia genetic testing
2019     Swiss Federal Office of Public Health (FOPH) Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2019     Swiss Federal Office of Public Health (FOPH) Assessment of knee arthroscopy for the treatment of degenerative changes
2019     Center for Evidence-based Practice (CEP) The Effect of Patient Communication About Medical Errors on Malpractice Lawsuits
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019     Center for Evidence-based Practice (CEP) Interventions to Reduce the Use of the High Risk Medications in Elderly Patients
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019     Center for Evidence-based Practice (CEP) Guidelines for Supplementary Feedings of Newborn Infants
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Atezolizumab (Tecentriq®) with nab-paclitaxel (Abraxane®) for the treatment of advanced triple-negative breast cancer (aTNBC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Evaluation methods for the benefit assessment of easily accessible, outpatient health centres for vulnerable groups - Target group focus: Homeless and non-insured persons
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Robot-assisted surgery in thoracic and visceral indications
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Alphanate - von Willebrand disease]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Annulus Fibrosus Repair after lumbar discectomy
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Single/two-step scaffold-based cartilage repair in the knee and ankle joint